PathAI vs Tempus

Side-by-side comparison of PathAI and Tempus: pricing, features, API access, and community ratings.

AI comparison summary

TL;DR: PathAI specializes in diagnostic pathology with FDA-cleared digital pathology tools and a massive network of 450+ pathologists creating training data, making it strongest for tissue-based diagnostics and biomarker discovery. Tempus offers broader precision medicine coverage by integrating genomics, imaging, and EHR data into one of the world's largest clinical databases, positioning it better for comprehensive treatment decision support across the oncology care continuum. Choose PathAI for pathology-specific workflows and diagnostic development; choose Tempus for multi-modal data integration and treatment planning.

PathAI
PathAI

AI-powered pathology platform to improve patient outcomes through precision diagnostics

Visit
Tempus
Tempus

AI-powered precision medicine platform for oncology and clinical insights

Visit
Category
Healthcare & biotech
Healthcare & biotech
Pricing
Enterprise
Enterprise
Starting price
Free tier
Audience
Technical
All audiences
API available
Open source
Self-hostable
Model provider
PathAI (proprietary)
Proprietary
Founded
2016
2015
Headquarters
Boston, USA
Chicago, USA
Key strengths
  • ·AI-powered pathology algorithms
  • ·Large proprietary pathologist contributor network (450+ board-certified pathologists)
  • ·Extensive annotation dataset (32.5M+ annotations)
  • ·FDA-cleared digital pathology platform (AISight® Dx)
  • ·One of the world's largest clinico-genomic databases
  • ·AI-driven oncology insights and companion diagnostics
  • ·Real-time data integration across genomics, imaging, and EHR
  • ·Supports physicians with treatment decision support